| Literature DB >> 26232199 |
Liesbet van de Wetering1, Job van Exel2, Ana Bobinac2, Werner B F Brouwer3.
Abstract
BACKGROUND: To judge whether an intervention offers value for money, the incremental costs per gained quality-adjusted life-year (QALY) need to be compared with some relevant threshold, which ideally reflects the monetary value of health gains. Literature suggests that this value may depend on the equity context in which health gains are produced, but the value of a QALY in relation to equity considerations has remained largely unexplored.Entities:
Mesh:
Year: 2015 PMID: 26232199 PMCID: PMC4661217 DOI: 10.1007/s40273-015-0311-x
Source DB: PubMed Journal: Pharmacoeconomics ISSN: 1170-7690 Impact factor: 4.981
Overview of attributes and levels
| Attributes | Levels |
|---|---|
| Quality of life without treatment (scale 0–100) | 45, 65, 85 |
| Age at death if untreated (scale 0–80) | 30, 50, 70 |
| Gain in quality of life | 5, 15, 25, 35 |
| Gain in life expectancy | 5, 10, 15, 20 |
| Increase of health insurance premium (euro) | 6, 12, 18, 24 |
Affected people: 2000 in age group 10, 4000 in age group 40 and 12,000 in age group 70
Fig. 1Question 1. Age group 10, version 1, choice set 1. Which of the groups below do you, as a decision maker, think should be treated?
Results from mixed logit and latent class models original attributes
| Age 10 | Age 40 | Age 70 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MMNL | Latent class | MMNL | Latent class | MMNL | Latent class | |||||||
| Class 1 | Class 2 | Class 3 | Class 1 | Class 2 | Class 3 | Class 1 | Class 2 | Class 3 | ||||
| Health gain (%) | 0.110** | 0.090** | 0.090** | 0.051** | 0.097** | 0.084** | 0.087** | 0.046** | 0.117** | 0.075** | 0.137** | 0.054** |
| Remaining health without treatment (%) | 0.028** | 0.070** | −0.035** | 0.015* | 0.032** | 0.082** | −0.013** | 0.022** | 0.022** | 0.052** | −0.046** | −0.001 |
| Increase in premium (€/month) | −0.063** | −0.042** | −0.049** | −0.119** | −0.052** | −0.016* | −0.054** | −0.123** | −0.074** | −0.060** | −0.050** | −0.133** |
| Constant | −0.494 | 1.263** | −1.877** | 1.286** | −0.752** | 1.652** | −1.254** | 1.450** | −0.863** | −0.011 | −1.646** | 0.427 |
| SD random parameters | ||||||||||||
| Health gain (%) | 0.059** | 0.043** | 0.081** | |||||||||
| Remaining health without treatment (%) | 0.084** | 0.062** | 0.066** | |||||||||
| Constant | 3.383** | 2.931** | 2.755** | |||||||||
| Probability of class membership | 0.476** | 0.407** | 0.117** | 0.400** | 0.496** | 0.104** | 0.567** | 0.304** | 0.130** | |||
| LL at convergence | −2219.3 | −2288.5 | −2194.2 | −2233.7 | −2054.0 | −2124.1 | ||||||
| MWTP for a QALY (per class) | €243.635 | €208.072 | €48.793 | €533.015 | €160.695 | €37.271 | €165.784 | €366.749 | €53.873 | |||
| MWTP for a QALY (95 % CI) | €197.663 | €206.408 (€125.993–€286.823) | €184.893 | €296.756 (€37.281–€556.233) | €209.588 | €212.322 (€136.454–€288.190) | ||||||
LL log likelihood, MMNL mixed multinomial logit model, SD standard deviation, MWTP marginal willingness to pay
** p < 0.001, * p < 0.1
Demographic statistics (N = 1205)
| Variable | Mean | SD | Min | Max |
|---|---|---|---|---|
| Age | 45.0 | 15.0 | 18 | 86 |
| Gender (% female) | 50.8 | |||
| Partner (% yes) | 67.0 | |||
| Children (% yes) | 58.3 | |||
| Monthly income (%) | ||||
| Group 1 (<€1000) | 23.5 | |||
| Group 2 (€1000–€1999) | 31.5 | |||
| Group 3 (€2000–€3499) | 32.3 | |||
| Group 4 (≥€3500) | 12.7 | |||
| Education status (%) | ||||
| Elementary school | 25.5 | |||
| High school | 42.1 | |||
| University | 32.4 | |||
| Health status | ||||
| VAS (0–100) | 80.1 | 15.0 | 15 | 100 |
| Opt-out (%) | 10.9 |
Number of observations per version of the questionnaire: 411 for age group 10; 410 for age group 40; 384 for age group 70; General population statistics: 45 years of age (18+), 50.9 % female (18+) and 33.0 % elementary school, 40.2 % high school, 26.8 % university (15+) [http://statline.cbs.nl/Statweb/?LA=en]
SD standard deviation, VAS visual analogue scale
Results from MNL and MMNL models with QALY gain and proportional shortfall
| Age 10 | Age 40 | Age 70 | ||||
|---|---|---|---|---|---|---|
| MNL | MMNL | MNL | MMNL | MNL | MMNL | |
| Health gain from treatment (QALY) | 0.092** | 0.133** | 0.170** | 0.243** | 0.735*** | 1.178** |
| Proportional shortfall | −0.016** | −0.025** | −0.021** | −0.032** | −0.016*** | −0.022** |
| Increase in health insurance premium (€/month) | −0.027** | −0.055** | −0.036** | −0.052** | −0.048*** | −0.075** |
| Constant | −1.251** | −3.324** | −1.693** | −3.875** | −1.554*** | −3.053** |
| SD random parameters | ||||||
| Health gain from treatment (QALY) | 0.007 | 0.107** | 0.810** | |||
| Proportional shortfall | 0.076** | 0.063** | 0.066** | |||
| Constant | 6.366** | 5.479** | 6.050** | |||
| Log-likelihood at convergence | −2723.392 | −2244.898 | −2590.386 | −2193.658 | −2466.932 | −2054.220 |
MNL multinomial logit model, MMNL mixed multinomial logit model, SD standard deviation
** p < 0.001, * p < 0.1
| In a study estimating the social marginal willingness to pay (MWTP) for QALY gains among the general public, we observed distinct preference patters with respect to the allocation of healthcare resources. |
| Among a considerable proportion of the public, MWTP per QALY was sensitive to the severity of illness. It was not at all sensitive to the age of care recipients. |
| These findings emphasize the importance of accounting for heterogeneity in preferences among the public on value-laden issues such as prioritizing health care, both in research and decision making. |
| Findings about equity considerations are, however, not consistent across studies. This underlines the need to further explore the monetary value of a QALY in relation to equity considerations. |
| Number of classes | Log Likelihood | AIC | BIC | |
|---|---|---|---|---|
| Age group 10 | 1 | −2723.39212 | 5454.8 | 5479.2 |
| 2 | −2473.78587 | 4965.6 | 5020.5 | |
| 3 | −2288.50549 | 4605.0 | 4690.4 | |
| 4 | −2271.26754 | 4580.5 | 4696.4 | |
| 5 | −2225.79214 | 4499.6 | 4645.9 | |
| 6 | −2202.77079 | 4463.5 | 4640.4 | |
| 7 | −2184.51031 | 4437.0 | 4644.4 | |
| 8 | −2178.68425 | 4435.4 | 4673.2 | |
| 9 | −2178.71372 | 4445.4 | 4713.7 | |
| 10 | – | – | – | |
| Age group 40 | 1 | −2590.38614 | 5188.8 | 5213.2 |
| 2 | −2342.04598 | 4702.1 | 4757.0 | |
| 3 | −2233.72689 | 4495.5 | 4580.8 | |
| 4 | −2186.88956 | 4411.8 | 4527.6 | |
| 5 | −2168.02966 | 4384.1 | 4530.4 | |
| 6 | −2157.85377 | 4373.7 | 4550.5 | |
| 7 | −2152.86299 | 4373.7 | 4581.0 | |
| 8 | −2131.83972 | 4341.7 | 4579.4 | |
| 9 | −2130.30804 | 4348.6 | 4616.8 | |
| 10 | −2120.76759 | 4339.5 | 4638.2 | |
| Age group 70 | 1 | −2466.93212 | 4941.9 | 4966.0 |
| 2 | −2224.51394 | 4467.0 | 4521.3 | |
| 3 | −2124.14160 | 4276.3 | 4360.7 | |
| 4 | −2080.06128 | 4198.1 | 4321.7 | |
| 5 | −2052.04820 | 4152.1 | 4296.8 | |
| 6 | – | – | – | |
| 7 | −2017.28796 | 4102.6 | 4307.6 | |
| 8 | −1993.56204 | 4065.1 | 4300.3 | |
| 9 | −1994.84877 | 4077.7 | 4343.0 | |
| 10 | −2002.77934 | 4103.6 | 4399.0 |
AIC Akaike Information Criterion; BIC Bayesian Information Criterion